CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants of procedural success.

The TAVI-CLOSE study evaluated the efficacy and safety of two femoral access closure strategies after TAVI: closure with a dual suture device (dual Perclose ProGlide) vs a hybrid strategy consisting of a single suture plus a vascular plug (Perclose + Angio-Seal).

This was a prospective, randomized, single-center study conducted in the United States, in which patients were assigned in a 1:1 ratio to one of the two vascular closure strategies. Clinical follow-up extended to 30 days.

The primary endpoint (PE) was a composite of major access-site related bleeding and major vascular complications according to VARC-3 definitions. Secondary endpoints included minor vascular complications and total hospitalization costs.

The incidence of the primary endpoint was 2.1% in the dual suture group vs 7.1% in the suture + plug group. The absolute risk difference was 5% (95% CI −3.8% to 13.8%), exceeding the predefined non-inferiority margin.

Read also: CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon.

No serious events such as death, limb ischemia, embolization, or vascular perforation were reported. Procedural duration, fluoroscopy time, contrast volume, and length of hospital stay (approximately 1.1 days in both groups) were similar between strategies. Likewise, no differences were observed in total hospitalization costs, with a mean cost of approximately $42,000.

TAVI-CLOSE is the first randomized study conducted in the United States comparing vascular closure strategies after TAVI. The study demonstrated a low overall complication rate, with dual suture device closure emerging as the reference strategy.

Presented by Imran Baig at Late Breaking Clinical Trials, CRT 2026, Washington, USA.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coil embolization of segmental arteries as a spinal cord protection strategy prior to complex endovascular repair of thoracoabdominal aorta

Spinal cord ischemia remains one of the most devastating complications in the repair of thoracoabdominal aneurysms, with incidences of up to 20–30% in extensive...

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...